Have a feature idea you'd love to see implemented?
Let us know!
AADI Aadi Bioscience Inc
Price (delayed)
$2.28
Market cap
$56.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.28
Enterprise value
$26.61M
Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which the Company believes that activation of Tie2 may have therapeutic potential. The
Highlights
The debt has contracted by 31% YoY and by 10% from the previous quarter
Aadi Bioscience's revenue has increased by 8% YoY and by 5% from the previous quarter
AADI's quick ratio is down by 28% year-on-year but it is up by 15% since the previous quarter
The company's equity fell by 42% YoY and by 13% QoQ
AADI's gross margin is down by 4% year-on-year
Key stats
What are the main financial stats of AADI
Market
Valuations
Earnings
Shares outstanding
24.65M
Market cap
$56.2M
Enterprise value
$26.61M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.81
Price to sales (P/S)
2.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
Revenue
$25.07M
EBIT
-$61.48M
EBITDA
-$60.83M
Free cash flow
-$56.43M
Per share
Balance sheet
Liquidity
EPS
-$2.28
Free cash flow per share
-$2.09
Book value per share
$2.8
Revenue per share
$0.93
TBVPS
$3.17
Total assets
$85.7M
Total liabilities
$16.83M
Debt
$946,000
Equity
$68.87M
Working capital
$61.5M
Debt to equity
0.01
Current ratio
4.89
Quick ratio
4.37
Net debt/EBITDA
0.49
Margins
Efficiency
Dividend
EBITDA margin
-242.6%
Gross margin
87.4%
Net margin
-246.1%
Operating margin
-264.2%
Return on assets
-57.3%
Return on equity
-71.9%
Return on invested capital
-151.2%
Return on capital employed
-88%
Return on sales
-245.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AADI stock price
How has the Aadi Bioscience stock price performed over time
Intraday
2.7%
1 week
5.07%
1 month
8.57%
1 year
-51.28%
YTD
12.87%
QTD
10.68%
Financial performance
How have Aadi Bioscience's revenue and profit performed over time
Revenue
$25.07M
Gross profit
$21.91M
Operating income
-$66.22M
Net income
-$61.69M
Gross margin
87.4%
Net margin
-246.1%
The operating margin rose by 12% YoY and by 11% QoQ
The net margin has grown by 10% from the previous quarter and by 10% YoY
Aadi Bioscience's revenue has increased by 8% YoY and by 5% from the previous quarter
The company's gross profit rose by 6% QoQ and by 3.6% YoY
Growth
What is Aadi Bioscience's growth rate over time
Valuation
What is Aadi Bioscience stock price valuation
P/E
N/A
P/B
0.81
P/S
2.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.06
The company's EPS rose by 6% QoQ
AADI's price to book (P/B) is 44% less than its 5-year quarterly average of 1.4 but 32% more than its last 4 quarters average of 0.6
The company's equity fell by 42% YoY and by 13% QoQ
The price to sales (P/S) is 91% less than the 5-year quarterly average of 25.2 but 9% more than the last 4 quarters average of 2.2
Aadi Bioscience's revenue has increased by 8% YoY and by 5% from the previous quarter
Efficiency
How efficient is Aadi Bioscience business performance
The return on invested capital has dropped by 122% year-on-year
The company's return on equity has shrunk by 57% YoY and by 8% QoQ
The return on assets has declined by 46% year-on-year and by 6% since the previous quarter
The company's return on sales rose by 10% QoQ and by 10% YoY
Dividends
What is AADI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AADI.
Financial health
How did Aadi Bioscience financials performed over time
Aadi Bioscience's total assets has decreased by 39% YoY and by 16% QoQ
AADI's quick ratio is down by 28% year-on-year but it is up by 15% since the previous quarter
The debt is 99% less than the equity
The company's equity fell by 42% YoY and by 13% QoQ
The debt has contracted by 31% YoY and by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.